| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642580A Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1642422A 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces |
| 07/20/2005 | CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 07/20/2005 | CN1211367C Prostaglandin agonists and their use to treat bone disorders |
| 07/20/2005 | CN1211362C New benzothiophene, benzofuran and indole compounds, process for their preparation and pharmaceutical compounds containing them |
| 07/20/2005 | CN1211361C Fused-ring carboxylic acid derivatives |
| 07/19/2005 | US6919375 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 07/19/2005 | US6919371 Antidiabetic agents; dietetics; gastrointestinal disorders |
| 07/19/2005 | US6919367 Substituted thioacetamides |
| 07/19/2005 | US6919359 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
| 07/19/2005 | US6919356 Antihistamines, antiallergens, autoimmune disease, antiinflammatory agents |
| 07/19/2005 | US6919355 Amide derivatives as NMDA receptor antagonists |
| 07/19/2005 | US6919354 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 07/19/2005 | US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens |
| 07/19/2005 | US6919339 ABCA-1 elevating compounds |
| 07/19/2005 | US6919338 Antiproliferative agents; anticancer agents |
| 07/14/2005 | WO2005063739A1 Novel quinoline derivatives |
| 07/14/2005 | WO2005063734A2 Substituted thiophenes |
| 07/14/2005 | WO2005063704A1 Azetidine ring compounds and drugs comprising the same |
| 07/14/2005 | WO2005063241A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates |
| 07/14/2005 | WO2005063020A1 Plant growth regulation |
| 07/14/2005 | WO2005037781A3 Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 07/14/2005 | WO2004108085A3 Methods for the protection of memory and cognition |
| 07/14/2005 | US20050154229 Salt formation from the free base and maleic acid in the presence of an alcohol solvent to obtain the amorphous salt form, and then recrystallization; thrombin inhibitors with optimal solubility and no deliquescence |
| 07/14/2005 | US20050154056 Inhibitors of HCV NS5B polymerase |
| 07/14/2005 | US20050154048 cysteine proteases, cathepsin K; bone metabolic enzymes inhibitor; bone resorption process; anticarcinogenic; 5-[1-(hydroxyimino)ethyl]-2-thiophenecarboxylic acid 2-[[(9H-fluoren-9-yl)methoxy]carbonyl]hydrazide; esterification and coupling with diamine compounds of thiophenecarboxylic acid derivatives |
| 07/14/2005 | US20050154039 5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
| 07/14/2005 | US20050154038 bicyclo[2.2.2]-oct-1-yl-1,2,4-triazoles; type 2 diabetes, lipid disorders, obesity, atherosclerosis, metabolic syndrome, hyperglycemia, insulin resistance; increase insulin sensitivity in muscle, liver and adipose tissue by correction of the elevated plasma levels of glucose without causing hypoglycemia |
| 07/14/2005 | US20050154023 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease |
| 07/14/2005 | US20050154019 Substituted cyclic amine metalloprotease inhibitors |
| 07/14/2005 | US20050154015 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/14/2005 | US20050154014 Anticarcinogenic agents; antitumor agents treating cancer of breast, head, neck, gastrointestinal system or stomach, ovaries, bronchi, lungs or pancreas; leukemia |
| 07/14/2005 | US20050154012 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/14/2005 | US20050154005 Administering to a subject in need of such treatment an effective amount of 1,1'-[1,4-(phenylenebis(methylene))]bis-1,4,8,11-tetraazacyclotetradecane or a pharmaceutical composition thereof, wherein the inhibition of CXCR4 receptor binding effects treatment or amelioration of said condition |
| 07/14/2005 | US20050153997 Fredericamycin derivatives |
| 07/14/2005 | US20050153987 Compounds |
| 07/14/2005 | US20050153986 Psychiatric and mood disorders, Bipolar Disorder, Circadian rhythm disorders, sleep disorders, pain, Parkinson's disease, cognitive dysfunction, epilepsy, obesity, drug addiction, drug abuse, drug withdrawal; side effects reduction; 1-Methyl-3-[3-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]imidazolidin-2-one |
| 07/14/2005 | US20050153966 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 07/14/2005 | US20050153965 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 07/14/2005 | US20050153960 Substituted arylamine derivatives and methods of use |
| 07/14/2005 | US20050153958 Substituted aryl ketones |
| 07/14/2005 | US20050153900 Novel inhibitors of hepatitis C virus NS3/NS4a serine protease |
| 07/14/2005 | US20050151973 Optical device utilizing plasmon resonance |
| 07/14/2005 | CA2550894A1 Plant growth regulation |
| 07/14/2005 | CA2550428A1 Substituted thiophenes |
| 07/13/2005 | EP1553179A1 Mouse-origin proteins forming domain or use thereof |
| 07/13/2005 | EP1553091A1 Heteroaromatic pentacyclic compound and medicinal use thereof |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1553084A1 Piperidine derivative, process for producing the same, and use |
| 07/13/2005 | EP1553074A1 Fused benzene derivative and use |
| 07/13/2005 | EP1551827A1 Piperidine derivatives as ccr5 inhibitors |
| 07/13/2005 | EP1551822A2 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 07/13/2005 | EP1551811A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
| 07/13/2005 | EP1551810A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 07/13/2005 | EP1551809A1 Pyrazole compounds for treatment of neurodegenerative disorders |
| 07/13/2005 | EP1551804A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/13/2005 | EP1551404A2 Method of inhibiting angiogenesis |
| 07/13/2005 | EP1551397A2 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 07/13/2005 | EP1551384A2 R-nsaid esters and their use |
| 07/13/2005 | EP1235802B1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 07/13/2005 | EP1161415B1 N-cyanomethylamides as protease inhibitors |
| 07/13/2005 | EP1042291B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 07/13/2005 | CN1639154A Pyranones useful as ATM inhibitors |
| 07/13/2005 | CN1639146A Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| 07/13/2005 | CN1639145A Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 07/13/2005 | CN1639132A N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/13/2005 | CN1639128A O-cyclopropyl-carboxanilides and their use as fungicides |
| 07/13/2005 | CN1639125A New inhibitors of histone deacetylase |
| 07/13/2005 | CN1639124A Aminotetralin derivatives as muscarinic receptor antagonists |
| 07/13/2005 | CN1639123A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/13/2005 | CN1639120A Indolamid derivatives which possess glycogenphosphorylase inhibitory activity |
| 07/13/2005 | CN1639119A Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 07/13/2005 | CN1638810A Near infrared fluorescent contrast agent and method for fluorescence imaging |
| 07/13/2005 | CN1638776A Substituted 3-aryl-5-aryl-[1, 2, 4]-oxadiazoles and analogs |
| 07/13/2005 | CN1638763A Antidepressant |
| 07/13/2005 | CN1638761A Azetidine derivatives as CCR-3 receptor antagonists |
| 07/13/2005 | CN1637624A Organophotoreceptor with charge transport material having a thiiranyl group |
| 07/13/2005 | CN1636994A Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636565A Modified form of the r(-)-n-(4, 4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride |
| 07/13/2005 | CN1210274C Piperazine and piperidine derivatives |
| 07/13/2005 | CN1210273C Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/13/2005 | CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
| 07/13/2005 | CN1210265C Phthalazine derivatives and remedies for erectile dysfunction |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/12/2005 | US6916940 Oxidation, fluorination, desulfurization |
| 07/12/2005 | US6916931 Tridentate ligands and relative complexes with transition metals |
| 07/12/2005 | US6916841 Inhibitors of phospholipase enzymes |
| 07/12/2005 | US6916819 Benzimidazole and pyridylimidazole derivatives |
| 07/12/2005 | US6916817 Inhibitors of metalloproteinases |
| 07/12/2005 | US6916813 (1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase |
| 07/12/2005 | US6916812 Dietetic agents |
| 07/12/2005 | US6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use |
| 07/12/2005 | US6916798 Inhibitors of glycogen synthase kinase-3 (GSK-3), a serine/threonine protein kinase; for treatment and prevention of diabetes and Alzheimer's disease |
| 07/07/2005 | WO2005061519A1 Kinase inhibitors |
| 07/07/2005 | WO2005061487A1 Hiv protease inhibiting compounds |